nodes	percent_of_prediction	percent_of_DWPC	metapath
SIMEPREVIR—CYP1A2—Carmustine—lymphatic system cancer	0.229	0.255	CbGbCtD
SIMEPREVIR—SLCO1B1—Methotrexate—lymphatic system cancer	0.137	0.153	CbGbCtD
SIMEPREVIR—ABCB1—Mitoxantrone—lymphatic system cancer	0.094	0.105	CbGbCtD
SIMEPREVIR—CYP3A4—Cytarabine—lymphatic system cancer	0.0818	0.0913	CbGbCtD
SIMEPREVIR—CYP3A4—Teniposide—lymphatic system cancer	0.0806	0.0899	CbGbCtD
SIMEPREVIR—ALB—Methotrexate—lymphatic system cancer	0.0749	0.0836	CbGbCtD
SIMEPREVIR—ABCB1—Vincristine—lymphatic system cancer	0.0647	0.0722	CbGbCtD
SIMEPREVIR—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0563	0.0629	CbGbCtD
SIMEPREVIR—ABCB1—Methotrexate—lymphatic system cancer	0.0392	0.0437	CbGbCtD
SIMEPREVIR—CYP3A4—Vincristine—lymphatic system cancer	0.0388	0.0433	CbGbCtD
SIMEPREVIR—Blood bilirubin increased—Mitoxantrone—lymphatic system cancer	0.00286	0.0274	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Mechlorethamine—lymphatic system cancer	0.00259	0.0249	CcSEcCtD
SIMEPREVIR—Infection—Mechlorethamine—lymphatic system cancer	0.00249	0.0238	CcSEcCtD
SIMEPREVIR—Skin disorder—Mechlorethamine—lymphatic system cancer	0.00243	0.0233	CcSEcCtD
SIMEPREVIR—Anaemia—Teniposide—lymphatic system cancer	0.00209	0.02	CcSEcCtD
SIMEPREVIR—Anaemia—Fludarabine—lymphatic system cancer	0.00184	0.0176	CcSEcCtD
SIMEPREVIR—Infection—Teniposide—lymphatic system cancer	0.00183	0.0176	CcSEcCtD
SIMEPREVIR—Pruritus—Mechlorethamine—lymphatic system cancer	0.00177	0.017	CcSEcCtD
SIMEPREVIR—Myalgia—Fludarabine—lymphatic system cancer	0.00169	0.0162	CcSEcCtD
SIMEPREVIR—Dyspnoea—Teniposide—lymphatic system cancer	0.00164	0.0158	CcSEcCtD
SIMEPREVIR—Infection—Fludarabine—lymphatic system cancer	0.00161	0.0154	CcSEcCtD
SIMEPREVIR—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.00159	0.0152	CcSEcCtD
SIMEPREVIR—Rash—Mechlorethamine—lymphatic system cancer	0.00158	0.0151	CcSEcCtD
SIMEPREVIR—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00158	0.0151	CcSEcCtD
SIMEPREVIR—Nausea—Mechlorethamine—lymphatic system cancer	0.00149	0.0143	CcSEcCtD
SIMEPREVIR—Hyperbilirubinaemia—Methotrexate—lymphatic system cancer	0.00148	0.0142	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00148	0.0142	CcSEcCtD
SIMEPREVIR—Dyspnoea—Fludarabine—lymphatic system cancer	0.00145	0.0139	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.0014	0.0134	CcSEcCtD
SIMEPREVIR—Fatigue—Fludarabine—lymphatic system cancer	0.0014	0.0134	CcSEcCtD
SIMEPREVIR—Constipation—Fludarabine—lymphatic system cancer	0.00139	0.0133	CcSEcCtD
SIMEPREVIR—Anaemia—Bleomycin—lymphatic system cancer	0.00135	0.0129	CcSEcCtD
SIMEPREVIR—Asthenia—Teniposide—lymphatic system cancer	0.00132	0.0127	CcSEcCtD
SIMEPREVIR—Pruritus—Teniposide—lymphatic system cancer	0.00131	0.0125	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Vincristine—lymphatic system cancer	0.00126	0.012	CcSEcCtD
SIMEPREVIR—Myalgia—Bleomycin—lymphatic system cancer	0.00124	0.0119	CcSEcCtD
SIMEPREVIR—Infection—Bleomycin—lymphatic system cancer	0.00118	0.0113	CcSEcCtD
SIMEPREVIR—Anaemia—Carmustine—lymphatic system cancer	0.00118	0.0113	CcSEcCtD
SIMEPREVIR—Asthenia—Fludarabine—lymphatic system cancer	0.00116	0.0112	CcSEcCtD
SIMEPREVIR—Rash—Teniposide—lymphatic system cancer	0.00116	0.0112	CcSEcCtD
SIMEPREVIR—Dermatitis—Teniposide—lymphatic system cancer	0.00116	0.0111	CcSEcCtD
SIMEPREVIR—Headache—Teniposide—lymphatic system cancer	0.00116	0.0111	CcSEcCtD
SIMEPREVIR—Pruritus—Fludarabine—lymphatic system cancer	0.00115	0.011	CcSEcCtD
SIMEPREVIR—Anaemia—Vincristine—lymphatic system cancer	0.00112	0.0108	CcSEcCtD
SIMEPREVIR—Photosensitivity—Methotrexate—lymphatic system cancer	0.00111	0.0107	CcSEcCtD
SIMEPREVIR—Nausea—Teniposide—lymphatic system cancer	0.0011	0.0105	CcSEcCtD
SIMEPREVIR—Anaemia—Mitoxantrone—lymphatic system cancer	0.00109	0.0105	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00108	0.0104	CcSEcCtD
SIMEPREVIR—Myalgia—Carmustine—lymphatic system cancer	0.00108	0.0104	CcSEcCtD
SIMEPREVIR—Dyspnoea—Bleomycin—lymphatic system cancer	0.00106	0.0102	CcSEcCtD
SIMEPREVIR—Myalgia—Vincristine—lymphatic system cancer	0.00103	0.00991	CcSEcCtD
SIMEPREVIR—Infection—Carmustine—lymphatic system cancer	0.00103	0.00988	CcSEcCtD
SIMEPREVIR—Rash—Fludarabine—lymphatic system cancer	0.00102	0.0098	CcSEcCtD
SIMEPREVIR—Dermatitis—Fludarabine—lymphatic system cancer	0.00102	0.00979	CcSEcCtD
SIMEPREVIR—Headache—Fludarabine—lymphatic system cancer	0.00102	0.00974	CcSEcCtD
SIMEPREVIR—Myalgia—Mitoxantrone—lymphatic system cancer	0.00101	0.00965	CcSEcCtD
SIMEPREVIR—Infection—Vincristine—lymphatic system cancer	0.000984	0.00944	CcSEcCtD
SIMEPREVIR—Nausea—Fludarabine—lymphatic system cancer	0.000963	0.00923	CcSEcCtD
SIMEPREVIR—Infection—Mitoxantrone—lymphatic system cancer	0.000958	0.00919	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000945	0.00906	CcSEcCtD
SIMEPREVIR—Insomnia—Carmustine—lymphatic system cancer	0.000939	0.009	CcSEcCtD
SIMEPREVIR—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000937	0.00898	CcSEcCtD
SIMEPREVIR—Dyspnoea—Carmustine—lymphatic system cancer	0.000925	0.00887	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000902	0.00865	CcSEcCtD
SIMEPREVIR—Insomnia—Vincristine—lymphatic system cancer	0.000896	0.00859	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000896	0.00859	CcSEcCtD
SIMEPREVIR—Constipation—Carmustine—lymphatic system cancer	0.000887	0.00851	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000879	0.00843	CcSEcCtD
SIMEPREVIR—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00086	0.00825	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000855	0.0082	CcSEcCtD
SIMEPREVIR—Fatigue—Vincristine—lymphatic system cancer	0.000854	0.00819	CcSEcCtD
SIMEPREVIR—Asthenia—Bleomycin—lymphatic system cancer	0.000853	0.00818	CcSEcCtD
SIMEPREVIR—Constipation—Vincristine—lymphatic system cancer	0.000847	0.00812	CcSEcCtD
SIMEPREVIR—Pruritus—Bleomycin—lymphatic system cancer	0.000841	0.00806	CcSEcCtD
SIMEPREVIR—Fatigue—Mitoxantrone—lymphatic system cancer	0.000832	0.00797	CcSEcCtD
SIMEPREVIR—Constipation—Mitoxantrone—lymphatic system cancer	0.000825	0.00791	CcSEcCtD
SIMEPREVIR—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000771	0.0074	CcSEcCtD
SIMEPREVIR—Rash—Bleomycin—lymphatic system cancer	0.00075	0.00719	CcSEcCtD
SIMEPREVIR—Dermatitis—Bleomycin—lymphatic system cancer	0.000749	0.00718	CcSEcCtD
SIMEPREVIR—Asthenia—Carmustine—lymphatic system cancer	0.000745	0.00714	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000713	0.00683	CcSEcCtD
SIMEPREVIR—Asthenia—Vincristine—lymphatic system cancer	0.000711	0.00681	CcSEcCtD
SIMEPREVIR—Nausea—Bleomycin—lymphatic system cancer	0.000706	0.00677	CcSEcCtD
SIMEPREVIR—Asthenia—Mitoxantrone—lymphatic system cancer	0.000692	0.00664	CcSEcCtD
SIMEPREVIR—Rash—Carmustine—lymphatic system cancer	0.000654	0.00627	CcSEcCtD
SIMEPREVIR—Dermatitis—Carmustine—lymphatic system cancer	0.000654	0.00627	CcSEcCtD
SIMEPREVIR—Headache—Carmustine—lymphatic system cancer	0.00065	0.00623	CcSEcCtD
SIMEPREVIR—Rash—Vincristine—lymphatic system cancer	0.000625	0.00599	CcSEcCtD
SIMEPREVIR—Dermatitis—Vincristine—lymphatic system cancer	0.000624	0.00598	CcSEcCtD
SIMEPREVIR—Headache—Vincristine—lymphatic system cancer	0.000621	0.00595	CcSEcCtD
SIMEPREVIR—Nausea—Carmustine—lymphatic system cancer	0.000616	0.00591	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.00061	0.00585	CcSEcCtD
SIMEPREVIR—Rash—Mitoxantrone—lymphatic system cancer	0.000608	0.00583	CcSEcCtD
SIMEPREVIR—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000608	0.00583	CcSEcCtD
SIMEPREVIR—Headache—Mitoxantrone—lymphatic system cancer	0.000604	0.00579	CcSEcCtD
SIMEPREVIR—Nausea—Vincristine—lymphatic system cancer	0.000588	0.00564	CcSEcCtD
SIMEPREVIR—Nausea—Mitoxantrone—lymphatic system cancer	0.000573	0.00549	CcSEcCtD
SIMEPREVIR—Anaemia—Methotrexate—lymphatic system cancer	0.000544	0.00522	CcSEcCtD
SIMEPREVIR—Myalgia—Methotrexate—lymphatic system cancer	0.000501	0.00481	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000498	0.00477	CcSEcCtD
SIMEPREVIR—Infection—Methotrexate—lymphatic system cancer	0.000477	0.00458	CcSEcCtD
SIMEPREVIR—Skin disorder—Methotrexate—lymphatic system cancer	0.000467	0.00448	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000438	0.0042	CcSEcCtD
SIMEPREVIR—Insomnia—Methotrexate—lymphatic system cancer	0.000435	0.00417	CcSEcCtD
SIMEPREVIR—Dyspnoea—Methotrexate—lymphatic system cancer	0.000429	0.00411	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000415	0.00398	CcSEcCtD
SIMEPREVIR—Fatigue—Methotrexate—lymphatic system cancer	0.000414	0.00397	CcSEcCtD
SIMEPREVIR—Asthenia—Methotrexate—lymphatic system cancer	0.000345	0.00331	CcSEcCtD
SIMEPREVIR—Pruritus—Methotrexate—lymphatic system cancer	0.00034	0.00326	CcSEcCtD
SIMEPREVIR—Rash—Methotrexate—lymphatic system cancer	0.000303	0.00291	CcSEcCtD
SIMEPREVIR—Dermatitis—Methotrexate—lymphatic system cancer	0.000303	0.0029	CcSEcCtD
SIMEPREVIR—Headache—Methotrexate—lymphatic system cancer	0.000301	0.00289	CcSEcCtD
SIMEPREVIR—Nausea—Methotrexate—lymphatic system cancer	0.000285	0.00274	CcSEcCtD
